Research articlePublished 2013
Mesenchymal Progenitor Cells from Different Sources and their Potential to Differentiate In Vitro into Muscle Cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The field of regenerative medicine requires a reliable source of therapeutic cells in the context of muscular dystrophies. Cell therapies are among the treatment options being considered with the advances in stem cells and scaffolding domain. Umbilical cord tissue, Dental pulp and adipose tissues are abundant sources for clinical grade mesenchymal stem cells. These cells can differentiate into multiple lineages. The isolation, characterization, transdifferentiation, cell- gel formations and clinical applications of stroma derived mesenchymal progenitors are compared with each other source to evaluate the regenerative capability invitro. Dental pulp derived mesenchymal stem cells showed more propensity towards myogenic transdifferentiation although the abundance of the source and ease of higher cell yield was observed with cord and adipose tissue.
Subjects
BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCell & Developmental Biology
- SubjectBiology
- BylineArticles whose byline prints “Ranjith Kumar Indarapu”
- BylineArticles whose byline prints “Leela Krishna”
- BylineArticles whose byline prints “Subhadra Dravida”
